As elevated expression of secreted protein acidic and rich in cysteine (SPARC) is associated with metastasis and a poor prognosis in NPC [23], evaluation of the relationship between SPARC expression and the clinical activity of nab-paclitaxel was an exploratory objective of the study. This evidence concerns the gene SPARC and nasopharyngeal carcinoma.